Evaluation of the myogenic effects of subthalamic nucleus deep brain stimulation at near therapeutic amplitudes
These findings support that STN-DBS-induced myogenic activity is commonplace at therapeutic stimulation amplitudes used clinically; thus, studies evaluating the degree to which myogenic effects during SoC STN DBS are associated with the clinical and side effects of STN DBS therapy are warranted.
Authors
- Kyle Baker
- Brett A. Campbell
- Carmen Toth
- Leonardo Favi Bocca
- Kenneth B. Baker
Institutions
- MetroHealth (US)
- Cleveland Clinic (US)
- Cleveland Clinic Lerner College of Medicine (US)
- MetroHealth Medical Center (US)
- The Neurological Institute (US)
- Case Western Reserve University (US)
Publication Details
- Journal
- Frontiers in Neuroscience
- Published
- 2026-01-29
- DOI
- https://doi.org/10.3389/fnins.2026.1733633
- Primary Topic
- Neurological disorders and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Farmer Family Foundation